8002:TSEMarubeni Corporation Analysis
Data as of 2026-03-10 - not real-time
¥5,413.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Marubeni Corp (8002.T) is trading at ¥5,413, comfortably above its 20‑day SMA (¥5,775) and 50‑day SMA (¥5,249) while still below the 52‑week high of ¥6,328, indicating a bullish bias with room to run. The RSI sits at 47, suggesting the stock is not yet overbought, and the MACD histogram is negative, flagging short‑term pressure but not a decisive reversal. Fundamentals show a solid 7.7% revenue growth, a respectable ROE of 12.9%, and a healthy dividend yield of 2.09% with a payout ratio under 30%, pointing to sustainable income. However, the DCF‑derived fair value of ¥754 is far below the market price, raising concerns of overvaluation despite a P/E of 15.7 that is well under the industry average of 29.5. The company’s beta of 0.58 and stable volume suggest modest market sensitivity, though a 30‑day volatility of 56% signals notable price swings.
Overall, the stock balances growth prospects from its diversified industrial portfolio with valuation headwinds; investors should weigh the strong dividend and earnings momentum against the price premium and elevated short‑term technical weakness.
Overall, the stock balances growth prospects from its diversified industrial portfolio with valuation headwinds; investors should weigh the strong dividend and earnings momentum against the price premium and elevated short‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above 20‑day SMA but MACD bearish signal
- RSI near neutral indicating limited upside
- Strong dividend yield supporting demand
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue growth and solid ROE
- P/E well below industry average
- Support level at ¥4,952 providing downside cushion
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Diversified global operations reducing single‑market exposure
- High debt‑to‑equity (63) offset by ample cash reserves
- Stable dividend policy offering income certainty
Key Metrics & Analysis
Financial Health
Revenue Growth7.70%
Profit Margin6.19%
P/E Ratio15.7
ROE12.85%
ROA2.07%
Debt/Equity63.00
P/B Ratio2.1
Op. Cash Flow¥540.8B
Free Cash Flow¥177.8B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI47.3
Support¥4,952.00
Resistance¥6,328.00
MA 20¥5,775.45
MA 50¥5,248.88
MA 200¥3,888.64
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value¥753.70
Target Price¥5,740.00
Upside/Downside6.04%
GradeOvervalued
TypeBlend
Dividend Yield2.09%
Risk Assessment
Beta0.58
Volatility55.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.